KLG Stock +78.58% In 3 Months Since We Picked KLG Stock +78.58% In 3 Months Since We Picked Unlock All Top Buy Picks
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of CSTL
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Castle Biosciences, Inc. stock upgraded to Hold/Accumulate.
(Updated on Apr 26, 2024)

Hold candidate since Apr 26, 2024 PDF

The Castle Biosciences, Inc. stock price gained 4.25% on the last trading day (Friday, 26th Apr 2024), rising from $19.51 to $20.34. During the last trading day the stock fluctuated 7.42% from a day low at $19.34 to a day high of $20.77. The price has been going up and down for this period, and there has been a 1.4% gain for the last 2 weeks. Volume fell on the last day by -71 thousand shares and in total, 107 thousand shares were bought and sold for approximately $2.18 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stockhas broken the very wide and falling short-term trend up. Firstly a slower falling rate is indicated, but this may very well be an early signal of a trend shift. On the reaction, there will be support on the roof of the current trend broken, which is $19.26, a level that may pose a second chance to hit a runner. According to fan-theory $23.76 will be the next possible trend-top level and thereby pose a resistance level that may not be broken at the first attempt.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

CSTL Signals & Forecast

The Castle Biosciences, Inc. stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $19.70 and $20.32. A breakdown below any of these levels will issue sell signals. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. A sell signal was issued from a pivot top point on Tuesday, March 05, 2024, and so far it has fallen -8.83%. Further fall is indicated until a new bottom pivot has been found. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for Castle Biosciences, Inc. stock

Castle Biosciences, Inc. finds support from accumulated volume at $20.06 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $1.44 between high and low, or 7.42%. For the last week, the stock has had daily average volatility of 4.64%.

Our recommended stop-loss: $19.21 (-5.58%) (This stock has medium daily movements and this gives medium risk. There is a sell signal from a pivot top found 37 days ago.)

Trading Expectations (CSTL) For The Upcoming Trading Day Of Monday 29th

For the upcoming trading day on Monday, 29th we expect Castle Biosciences, Inc. to open at $20.15, and during the day (based on 14 day Average True Range), to move between $19.42 and $21.26, which gives a possible trading interval of +/-$0.92 (+/-4.50%) up or down from last closing price. If Castle Biosciences, Inc. takes out the full calculated possible swing range there will be an estimated 9.00% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $20.06 (1.38%) than the resistance at $21.23 (4.38%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Earnings coming up

Castle Biosciences, Inc. will release earnings AMC on Thursday, May 02, 2024.The consensus among the analysts for the expected earnings (EPS) is -$0.370. We will update the financials statements for Castle Biosciences, Inc., that can be found here as soon as the records are public. Our systems has calculated a possible swing of +/- 7.06% in the first trading day after earnings release.

Is Castle Biosciences, Inc. stock A Buy?

Castle Biosciences, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

Current score: -0.879 Hold/Accumulate Upgraded

Predicted Opening Price for Castle Biosciences, Inc. of Monday, April 29, 2024

Fair opening price April 29, 2024 Current price
$20.15 ( 0.94%) $20.34

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for CSTL

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 21.58 6.11 %
R2 21.04 3.42 %
R1 20.70 1.75 %
Current price: 20.34
Support S1 19.60 -3.64 %
S2 19.26 -5.30 %
S3 18.71 -8.00 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 25.09 23.35 %
R2 22.31 9.69 %
R1 21.23 4.38 %
Current price 20.34
Support S1 20.06 -1.38%
S2 19.94 -1.97%
S3 18.06 -11.21%

FAQ

What is the symbol for Castle Biosciences, Inc. Stock and on which exchange is it traded?
The symbol for Castle Biosciences, Inc. is CSTL and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell Castle Biosciences, Inc. Stock?
Castle Biosciences, Inc. holds several negative signals and this should be a sell candidate, but due to the general chance for a turnaround situation it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development. We have upgraded our analysis conclusion for this stock since the last evaluation from a Sell to a Hold/Accumulate candidate.

How to buy Castle Biosciences, Inc. Stock?
Castle Biosciences, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Castle Biosciences, Inc. Stock.

What's the current price of Castle Biosciences, Inc. Stock?
As of the end of day on the Apr 26, 2024, the price of an Castle Biosciences, Inc. (CSTL) share was $20.34.

What is the 52-week high and low for Castle Biosciences, Inc. Stock?
The 52-week high for Castle Biosciences, Inc. Stock is $26.70 and the 52-week low is $9.26.

What is the market capitalization of Castle Biosciences, Inc. Stock?
As of the Apr 26, 2024, the market capitalization of Castle Biosciences, Inc. is 535.55M.

When is the next earnings date for Castle Biosciences, Inc.?
The upcoming earnings date for Castle Biosciences, Inc. is May 02, 2024.
Click to get the best stock tips daily for free!

About Castle Biosciences, Inc.

Castle Biosciences. Castle Biosciences, Inc., a commercial-stage diagnostics company, focuses to provide diagnostic and prognostic testing services for dermatological cancers. Its lead product is DecisionDx-Melanoma, a multi-gene expression profile (GEP) test to identify the risk of metastasis for patients diagnosed with invasive cutaneous melanoma. The company also offers DecisionDx-UM test, a proprietary GEP test that predicts the risk of metastasis for patients w... CSTL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT